Huons Co., Ltd.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Korea, South
- Registered address
- 100, Bio valley-ro, Jecheon-si, Chungcheongbuk-do 27159, Korea, South (KOR)
- Operations here
- manufacture
- FDA identifiers
- FEI 3007163376 · DUNS 631099384
Recent inspection flagged official action
FDA classified an inspection here as OAI (official action indicated) within the last two years — the strongest public warning signal a facility gets. This plant is listed on labels for 5 drugs, 3 already in shortage. A supply problem here can ripple to all of them.
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- OAIDrug Quality Assurance2025-11-21
- VAIDrug Quality Assurance2019-10-18
- VAIDrug Quality Assurance2016-11-02
Drugs this plant is listed as making
5 distinct drugs across 10 products name this site in their FDA label.
- Bupivacaine hydrochloridein shortageHuons Co., Ltd.
- lidocaine hydrochloridein shortageNovagenix Labs LLC
- Lidocaine Hydrochloride Anhydrousin shortageSpectra Medical Devices, LLC
- Sodium ChlorideSpectra Medical Deviecs, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.